Prostate-specific Antigen Density
Prostate-Specific Antigen Density is a clinical metric that quantifies the concentration of prostate-specific antigen relative to the volume of the prostate gland, typically expressed as nanograms per milliliter of serum per gram of prostate tissue, used to enhance the specificity of prostate cancer detection.
1.2K
Publications
71.1K
Citations
6K
Authors
1.5K
Institutions
Publications per year
2017–2026
263
Variants
Psa Density
1.2K
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
Ryan Phillips, William Y. Shi, Matthew P. Deek et al. · JAMA Oncology · 2020 · 1.1K citations · Full text
1–5 of 1.2K
6K
16
h-index
16
h-index
University of California, San Francisco, United States
16 publications · 1.8K citations
15
h-index
14
h-index
12
h-index
1–5 of 6K
1.5K

Johns Hopkins University
Baltimore, United States
30 h-index
257 publications
49.2K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
25 h-index
125 publications
8K citations

University of Toronto
Toronto, Canada
24 h-index
80 publications
4.8K citations
Memorial Sloan Kettering Cancer Center
New York, United States
21 h-index
73 publications
4.7K citations
University of California, Los Angeles
Los Angeles, United States
21 h-index
100 publications
5.3K citations
University of California, San Francisco
San Francisco, United States
21 h-index
111 publications
7.7K citations

Johns Hopkins Medicine
Baltimore, United States
17 h-index
116 publications
30.8K citations
University College London
London, United Kingdom
17 h-index
124 publications
8.7K citations
1–8 of 1.5K
176 publications · 15.5K citations
70
h-index
108 publications · 6.2K citations
45
h-index
59 publications · 3.7K citations
35
h-index
34 publications · 2.4K citations
28
h-index
46 publications · 2.1K citations
26
h-index
1–5